Abstract:Background: Error-corrected next-generation sequencing (ecNGS) technologies have enabled the direct evaluation of genome-wide mutations after exposure to mutagens. Previously, we reported an ecNGS methodology, Hawk-Seq™, and demonstrated its utility in evaluating mutagenicity. The evaluation of technical transferability is essential to further evaluate the reliability of ecNGS-based assays. However, cutting-edge sequencing platforms are continually evolving, which can affect the sensitivity of ecNGS. Therefore, the effect of differences in sequencing instruments on mutation data quality should be evaluated. Results: We assessed the performance of four sequencing platforms (HiSeq2500, NovaSeq6000, NextSeq2000, and DNBSEQ-G400) with the Hawk-Seq™ protocol for mutagenicity evaluation using DNA samples from mouse bone marrow exposed to benzo[a]pyrene (BP). The overall mutation (OM) frequencies per 106 bp in vehicle-treated samples were 0.22, 0.36, 0.46, and 0.26 for HiSeq2500, NovaSeq6000, NextSeq2000, and DNBSEQ-G400, respectively. The OM frequency of NextSeq2000 was significantly higher than that of HiSeq2500, suggesting the difference to be based on the platform. The relatively higher value in NextSeq2000 was a consequence of the G:C to C:G mutations in NextSeq2000 data (0.67 per 106 G:C bp), which was higher than the mean of the four platforms by a ca. of 0.25 per 106 G:C bp. A clear dose-dependent increase in G:C to T:A mutation frequencies was observed in all four sequencing platforms after BP exposure. The cosine similarity values of the 96-dimensional trinucleotide mutation patterns between HiSeq and the three other platforms were 0.93, 0.95, and 0.92 for NovaSeq, NextSeq, and DNBSeq, respectively. These results suggest that all platforms can provide equivalent data that reflect the characteristics of the mutagens. Conclusions: All platforms sensitively detected mutagen-induced mutations using the Hawk-Seq™ analysis. The substitution types and frequencies of the background errors differed depending on the platform. The effects of sequencing platforms on mutagenicity evaluation should be assessed before experimentation.

Evaluation of Chemical Mutagenicity Using Next Generation Sequencing: A Review

Next Generation Sequencing Technology and Its Application in Detecting Gene Mutations

Genotoxicity Testing and Recent Advances

[The Application of Transgenic Plant in Evaluating the Genotoxicity of Environmental Contaminants].

Toxicogenomics and Cancer Susceptibility: Advances with Next-Generation Sequencing

Application of Next-Generation Sequencing in the Detection of Low-Abundance Mutations.

Toxicogenomics and cancer susceptibility: advances with next-generation sequencing.

Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing

Assessment of in vivo chemical mutagenesis by long-read sequencing

Effect of sequencing platforms on the sensitivity of chemical mutation detection using Hawk-SeqTM

A Quantitative Toxicogenomics Assay for High-throughput and Mechanistic Genotoxicity Assessment and Screening of Environmental Pollutants

Effect of sequencing platforms on the sensitivity of chemical mutation detection using Hawk-Seq™

Assessment of Genotoxic Chemicals Using Chemogenomic Profiling Based on Gene-Knockout Library in Saccharomyces Cerevisiae.

Review of Current and “omics” Methods for Assessing the Toxicity (genotoxicity, Teratogenicity and Nephrotoxicity) of Herbal Medicines and Mushrooms

Next-Generation Sequencing Technology: Current Trends and Advancements

Characterizing Benzo[a]pyrene-induced lacZ mutation spectrum in transgenic mice using next-generation sequencing

Next-generation sequencing in the clinic: Promises and challenges

17. Application of Next-Generation Sequencing in Diagnosis of Patients with MDS and AML

An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies

Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing

Genome-wide direct quantification of in vivo mutagenesis using high-accuracy paired-end and complementary consensus sequencing